IMSOL INNOVATIVE MEDICAL SOLUTIONS INC.

What IMSOL INNOVATIVE MEDICAL SOLUTIONS INC. does

Innovative Medical Solutions (IMS) is a privately held U.S. medical supply distributor founded in 2021 and headquartered at 224 West 35th Street, New York. The company sources and distributes specialized medical equipment and consumables to medical suppliers, hospitals, and healthcare facilities worldwide, organized into six solution categories: Nuclear Medicine Solutions (synthesis and dispensing hot cells, radiopharmaceutical injectors, monitoring systems, shielded doors, waste plants, generators); Barrier Isolation Solutions (stainless steel isolator systems for nuclear technology hygiene); PET Tracer Production and Development Solutions (Trasis AllinOne and Easy One synthesizers with ready-to-use cassettes and reagent packs supporting over 30 radiotracers); COVID-19 Solutions (SD Biosensor Standard Q rapid antigen tests and TemaSinergie UVD disinfection robots); Radiotherapy and Uro-Oncology Solutions (dosimetry, quality assurance, hyperthermia, stereotactic and focal therapy systems, and patient transfer/positioning units); and Marketing Solutions (professional services for healthcare supply businesses).

The technology footprint is fundamentally distribution-led rather than built in-house: IMS does not own the underlying medical equipment IP, which is supplied by named partners Trasis (synthesizers), SD Biosensor (COVID diagnostics), and TemaSinergie (UVD robots). Its differentiation rests on partner curation, regulatory and clinical familiarity with nuclear/radiotherapy buyer requirements, and the bundling of high-value capital equipment with recurring consumables such as Trasis cassettes and reagent packs. There are no proprietary patents, in-house software platforms, APIs, applications, or AI/ML capabilities disclosed in the available data.

IMS operates a sales-led, direct go-to-market model with a 'Contact Us' call-to-action, email at [email protected], and phone-based inquiry handling. Revenue is generated through hardware sales of distributed medical equipment and consumables, supplemented by a smaller professional services stream from the Marketing Solutions offering. Pricing is not publicly disclosed; quotes are handled via direct engagement. The company claims a global customer footprint but maintains a single New York office, and discloses no headcount, revenue, funding, ownership, or management team details.

Name

IMSOL INNOVATIVE MEDICAL SOLUTIONS INC.

Legal name

Innovative Medical Solutions

Website

https://imeds.us

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Innovative Medical Solutions is a privately held New York-based distributor founded in 2021 that supplies nuclear medicine, radiotherapy, barrier isolation, PET tracer production, and COVID-19 equipment to medical suppliers, hospitals, and healthcare facilities worldwide via a direct sales model.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Equipment and Supplies Distribution: The company distributes a wide range of medical equipment and supplies including nuclear medicine systems, radiotherapy devices, PET tracer synthesizers, barrier isolation systems, COVID-19 diagnostic tests, and UVD robots to healthcare clients worldwide. Revenue is generated through the sale of equipment and consumable supplies with recurring demand from established supplier relationships.
2. Marketing Solutions Services: The company offers marketing strategy development services to help healthcare supply businesses boost sales and brand awareness, suggesting a professional services revenue stream.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Innovative Medical Solutions (IMS) is a New York-based medical supply distributor that supplies hospitals, medical suppliers, and healthcare facilities worldwide with specialized equipment and consumables across nuclear medicine, radiotherapy, barrier isolation, PET tracer production, and COVID-19 disinfection. The company operates as a value-added distributor built around partnerships with manufacturers such as Trasis, SD Biosensor, and TemaSinergie, complementing its equipment portfolio with marketing strategy services for healthcare supply businesses.

Product overview

Innovative Medical Solutions (IMS) is a medical supplier that combines sustainable medical traditions with technological innovations to provide cutting-edge medical products and supplies. The company operates as a single unified product/service offering organized around specialized solution categories: Nuclear Medicine Solutions (comprising synthesis hot cells, radiopharmaceutical injectors, monitoring systems, and ancillary equipment), Barrier Isolation Solutions (stainless steel isolator systems), PET Tracer Production Solutions (including AllinOne and Easy One Trasis synthesizers with supporting cassettes and reagents), COVID-19 Solutions (diagnostic tests and UV disinfection robots), Radiotherapy and Uro-Oncology Solutions (dosimetry and therapy systems), and Marketing Solutions. The portfolio is structured as a complementary set of specialized product lines rather than a single platform with modules.

Differentiator

Problem solved

Functional benefit

Products and services

• Nuclear Medicine Solutions

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• SD BiosensorcoreTechnology or IntegrationSD Biosensor supplies the Standard Q COVID-19 diagnosis tests, which IMS distributes as part of its COVID-19 Solutions portfolio. These rapid antigen tests enable quick and effective COVID-19 detection for healthcare system clients worldwide.
• TemaSinergiecoreTechnology or IntegrationTemaSinergie supplies UVD Robots for IMS's COVID-19 Solutions. These UV disinfection robots help healthcare system clients reduce the diffusion of harmful microorganisms, making environments disinfected and safe from bacteria and viruses.
• Trasis (AllinOne and Easy One Synthesizers)coreTechnology or IntegrationTrasis provides radiopharmaceutical synthesizers (AllinOne and Easy One) for IMS's PET Tracer Production and Development Solutions. The synthesizers feature open software for free layout and sequence editing, flexible technical configuration, and collaboration platforms. They support production of over 30 different radiotracers with comprehensive ready-to-use cassettes and reagent packs.

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• McKesson Corporation: One of the largest medical-surgical distributors in North America, serving hospitals, pharmacies, and healthcare providers globally. Comparable to IMS as a peer medical equipment and supplies distributor, but operates at vastly greater scale across broad product lines rather than IMS's nuclear/radiotherapy specialization.
• Owens & Minor: Medical products distribution and supply chain solutions company serving hospitals and healthcare systems. Like IMS, acts as a wholesale channel for medical equipment and supplies to healthcare providers, though Owens & Minor is significantly larger and focuses on commodity medical/surgical supplies.
• Siemens Healthineers: Global medical technology company offering imaging, nuclear medicine (PET cyclotrons, radiopharmacy solutions), and radiotherapy systems. Comparable to IMS in nuclear medicine and radiotherapy product categories, though Siemens operates as both manufacturer and broader solutions provider rather than specialty distributor.
• Henry Schein: Healthcare distributor specializing in dental, medical, and animal health products to office-based practitioners and institutions. Comparable distribution model to IMS though with broader coverage; both serve as intermediaries between medical device OEMs and end-user healthcare providers.
• Cardinal Health: Major medical product distributor serving hospitals, ambulatory sites, and clinical laboratories across the US. Overlaps with IMS in the wholesale distribution of medical equipment and supplies to healthcare providers, though Cardinal Health's portfolio is far broader and includes pharmaceutical distribution.
• Medline Industries: Largest privately held manufacturer and distributor of medical supplies and clinical solutions in the US. Comparable to IMS as a medical supplies distribution peer serving healthcare providers, though Medline's vertically integrated manufacturing-plus-distribution model differs from IMS's pure distributor approach.
• GE HealthCare: Major manufacturer and provider of medical imaging, nuclear medicine, and radiotherapy equipment including PET systems. Overlaps with IMS in the nuclear medicine and radiotherapy equipment space but as an OEM rather than distributor; competes indirectly as IMS's principals may also sell directly.

Others

• Trasis: Manufacturer of the AllinOne and Easy One radiopharmaceutical synthesizers that IMS distributes. Directly comparable technology offering (PET tracer production systems) but functions as IMS's supplier rather than competitor; included as an adjacent ecosystem participant whose product strategy shapes IMS's portfolio.

Emerging players

• Curium Pharma: Worldwide radiopharmaceutical manufacturer and distributor serving nuclear medicine departments. Comparable to IMS as a peer serving the nuclear medicine supply chain, with both companies providing products that support radiopharmaceutical production and administration at hospitals and imaging centers.

Direct peers

• Patterson Companies: Dental and animal health product distributor with a growing medical segment. While not directly competing in nuclear medicine, Patterson represents a comparable specialty-focused medical distributor model—curating niche technology portfolios and serving specialized healthcare providers rather than mass-market channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/innovativemedicalsolutions

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IMSOL INNOVATIVE MEDICAL SOLUTIONS INC.